Urgent recall of painkiller tablets due to crucial labelling error
Sentiment Mix
Geography
Expert Signals
GB News - News
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Omega Pharma Limited has initiated an urgent recall of its Napralief 250mg Gastro-Resistant Tablets after discovering crucial safety and dosage details were omitted from the product packaging.The precautionary measure affects three specific batches, which consumers can identify by checking for batch numbers B51496, B51497, and B51102 on their medication boxes.The painkiller, which contains naproxen as its active ingredient, is a non-steroidal anti-inflammatory drug commonly used to treat conditions ranging from muscle and joint pain to period discomfort.The Medicines and Healthcare products Regulatory Agency has advised anyone with concerns about their medication to seek medical guidance promptly.
Supported by 1 story
Related Events
The Best GLP-1 Drug on the Market Is Even Better Than We Knew - Gizmodo
Industry • 4/24/2026
Teddi Mellencamp admits she asked her doctor for GLP-1s after gaining weight during cancer treatment
Uncategorized • 4/25/2026
Pentagon cracks open Biden’s botched Afghan withdrawal as sweeping report readies all the receipts
Uncategorized • 4/25/2026
Experts reveal how to spot fake 'Wagyu' so you don't get ripped off on premium beef
Uncategorized • 4/24/2026
JetBlue allegedly used private customer data like internet history without consent to set prices, per lawsuit
Uncategorized • 4/25/2026